News

The randomized, double-blind, placebo-controlled Phase 3 study is designed to evaluate the safety and efficacy of palifosfamide and doxorubicin compared to doxorubicin and placebo, with no crossover between

Clinical benefit with INNO-206 at the maximum tolerated dose was shown in 10 of 13 (76.9%) evaluable patients with relapsed or refractory soft tissue sarcoma. In addition, five

As per the agreement, Astellas will transfer ownership of ASP7147, a bombesin BB2 receptor antagonist for the treatment of irritable bowel syndrome with diarrhea, to Seldar Pharma. Seldar,

The ColoPrint assay provides critical additional information for treatment decisions for stage II colon cancer patients who have undergone surgery. ColoPrint also helps in eliminating the gray area

Amyvid aids in the evaluation of adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease and other causes of cognitive decline. Cardinal Health Nuclear Pharmacy

Wild berry flavored athletic based energy drink will be developed as the first flavor of Energize Pro. The company said Energize Pro’s development is based on its existing

A supplemental new drug application was submitted to FDA for Promacta (eltrombopag) as a treatment for thrombocytopenia in adult patients with chronic hepatitis C infection to permit the

Amyvid loses over half of its radioactivity every two hours because of which it must be distributed directly to imaging centers from the specialized radiopharmacies where it is

The fully-human antibody targets the inhibitory receptor expressed on activated T-cells called PD-1 or programmed death-1. In the dose-ranging study 003, the anti-PD-1 immunotherapy (BMS-936558), showed clinical activity